Showing results (1101-1110 of 1,547) with videos related to

Sort By:
Pageof 155
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with afliberceptJohn F de Groot, Yuji Piao, Hai Tran, et al.
The Lancet. Oncology|August 21, 2020
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trialVivek Subbiah, Ulrik Lassen, Elena Élez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma <i>In Situ</i> to Invasive Ductal CarcinomaFresia Pareja, David N Brown, Ju Youn Lee, et al.
NPJ Breast Cancer|October 21, 2020
The genomic landscape of metastatic histologic special types of invasive breast cancerFresia Pareja, Lorenzo Ferrando, Simon S K Lee, et al.
Cancer Medicine|August 25, 2019
Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastomaEudocia Q Lee, Alona Muzikansky, Dan G Duda, et al.
Neuro-Oncology|November 19, 2022
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticityJamie A Dean, Shyam K Tanguturi, Daniel Cagney, et al.
Neuro-Oncology|May 21, 2024
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncologyRifaquat Rahman, Diana D Shi, Zachary J Reitman, et al.
Neuro-Oncology|January 23, 2019
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applicationsAdrienne Boire, Dieta Brandsma, Priscilla K Brastianos, et al.
Journal of Neuro-Oncology|November 29, 2019
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastomaMartin van den Bent, Analia Azaro, Filip De Vos, et al.
Pageof 155